Grant: Discovery Grants Program - Individual
Université Laval
$28,200.00
Crosstalk between hCG and the IL 1 system at the embryo-maternal interface: role in early implantation and pregnancy
FY 2010-11
Summary
Implantation requires a complex dialogue between an embryo competent to implant and an endometrium able to respond to it. Human chorionic gonadotropin (hCG) is the key hormone involved in such a dialogue. According to our recent data, this embryo's secreted hormone appears to directly induce secretion of major growth and angiogenic factors by endometrial cells, thereby promoting embryo implantation. More recent data from our laboratory revealed a new mechanism by which hCG modulates and rather boosts up endometrial cell receptivity to interleukin 1 (IL1), one of the earliest embryonic signal. Actually, hCG appears to alleviate cell surveillance of IL1 by markedly reducing the levels of its potent and specific inhibitor (the IL1 decoy receptor 2), without affecting IL1 receptor (the type 1) which mediates cell activation. This may have a considerable relevance for embryo implantation and development, considering the well-documented effects of IL1 in promoting cell survival, tissue remodeling and angiogenesis. The general and long-term objective of our research program is to elucidate the mechanisms of feto/maternal crosstalk during embryo implantation and pregnancy. At the short term, our objective is to elucidate the impact of hCG/IL1 interplay/synergism at the embryo-maternal interface by studying in vitro in cell culture and in vivo using mice models the inherent capability of hCG to regulate angiogenesis and cell survival, together with its indirect effects via the modulation of endometrial cell receptivity to IL1. This study may have a considerable interest for a better understanding of the mechanisms governing successful embryo implantation and development and ultimately for understanding of implantation failure-related infertility.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
355944-2008
Name nom
Akoum, Ali
Department département
Obstétrique et gynécologie
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2008
Award amount
28200
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5500
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal biology
Research subject fr
Biologie animale
Partie
3
Nb partie
5
Application title
Crosstalk between hCG and the IL 1 system at the embryo-maternal interface: role in early implantation and pregnancy
Keyword
NSERC
Application summary
Implantation requires a complex dialogue between an embryo competent to implant and an endometrium able to respond to it. Human chorionic gonadotropin (hCG) is the key hormone involved in such a dialogue. According to our recent data, this embryo's secreted hormone appears to directly induce secretion of major growth and angiogenic factors by endometrial cells, thereby promoting embryo implantation. More recent data from our laboratory revealed a new mechanism by which hCG modulates and rather boosts up endometrial cell receptivity to interleukin 1 (IL1), one of the earliest embryonic signal. Actually, hCG appears to alleviate cell surveillance of IL1 by markedly reducing the levels of its potent and specific inhibitor (the IL1 decoy receptor 2), without affecting IL1 receptor (the type 1) which mediates cell activation. This may have a considerable relevance for embryo implantation and development, considering the well-documented effects of IL1 in promoting cell survival, tissue remodeling and angiogenesis. The general and long-term objective of our research program is to elucidate the mechanisms of feto/maternal crosstalk during embryo implantation and pregnancy. At the short term, our objective is to elucidate the impact of hCG/IL1 interplay/synergism at the embryo-maternal interface by studying in vitro in cell culture and in vivo using mice models the inherent capability of hCG to regulate angiogenesis and cell survival, together with its indirect effects via the modulation of endometrial cell receptivity to IL1. This study may have a considerable interest for a better understanding of the mechanisms governing successful embryo implantation and development and ultimately for understanding of implantation failure-related infertility.